行情

MYOK

MyoKardia
MYOK
NASDAQ
已退市
市盈率(FWD)
市销率
市净率
市值
-36.4510
784.26
14.19
11,992,854,338.64
百时美施贵宝(Bristol Myers)第四季度获利超过市场预期
reuters.com · 02/04 11:59
百时美施贵宝(BMY.US)完成收购MyoKardia(MYOK.US)100%股权,涉资131亿美元
智通财经网 · 2020/11/18 06:40
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16)
Benzinga · 2020/11/17 13:31
MyoKardia Highlights Presentation Of Mavacamten Clinical, Non-Clinical Data At American Heart Association Sessions
MyoKardia, Inc. (NASDAQ:MYOK) today presented clinical and non-clinical data related to mavacamten, MyoKardia’s investigative therapeutic in late-stage development for the potential treatment of hypertrophic
Benzinga · 2020/11/13 15:02
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12)
Benzinga · 2020/11/13 12:40
Bristol-Myers Squibb Company -- Moody's assigns A2 to Bristol-Myers' sr. notes; outlook negative
finviz · 2020/11/09 14:03
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 5)
Benzinga · 2020/11/06 12:47
MyoKardia Q3 EPS $(1.60) Up From $(3.07) YoY
MyoKardia (NASDAQ:MYOK) reported quarterly losses of $(1.60) per share. This is a 47.88 percent increase over losses of $(3.07) per share from the same period last year.
Benzinga · 2020/11/05 21:15
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解MYOK最新的财务预测,通过MYOK每股收益,每股净资产,每股现金流等数据分析MyoKardia近期的经营情况,然后做出明智的投资选择。
分析师评级

9位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测MYOK价格均价为214.80,最高价位225.00,最低价为123.00。
EPS
机构持股
总机构数: 336
机构持股: 6,103.88万
持股比例: 114.47%
总股本: 5,332.29万
类型机构数股数
增持
78
502.92万
建仓
83
-67.78万
减持
76
279.76万
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+0.79%
制药与医学研究
+0.65%
高管信息
Non-Executive Chairman/Independent Director
Mark Perry
President/Chief Executive Officer/Director
Tassos Gianakakos
Chief Financial Officer
Taylor Harris
Executive Vice President
William Fairey
Chief Scientific Officer
Robert McDowell
General Counsel/Secretary
Denelle Waynick
Other
Jake Bauer
Independent Director
Sunil Agarwal
General Counsel
Cynthia J. Ladd
Independent Director
Mary Cranston
Independent Director
David Meeker
Independent Director
Kimberly Popovits
Independent Director
Wendy Yarno
暂无数据

微牛提供MyoKardia(NASDAQ-MYOK)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的MYOK股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易MYOK股票基本功能。